Bone marrow findings in Erdheim-Chester disease: increased prevalence of chronic myeloid neoplasms
- 17 October 2019
- journal article
- letter
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 105 (2) , e84-e86
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman DiseaseMayo Clinic Proceedings, 2019
- Concomitant Erdheim‐Chester disease and chronic myelomonocytic leukaemia: genomic insights into a common clonal originBritish Journal of Haematology, 2019
- Erdheim-Chester disease associated with chronic myelomonocytic leukemia harboring the same clonal mutationHaematologica, 2019
- High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosisBlood, 2017
- Flow cytometry based monocyte subset analysis accurately distinguishes chronic myelomonocytic leukemia from myeloproliferative neoplasms with associated monocytosisBlood Cancer Journal, 2017
- Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cellsBlood, 2017
- Adult disseminated Langerhans cell histiocytosis: incidence, racial disparities and long‐term outcomesBritish Journal of Haematology, 2017
- Diverse and Targetable Kinase Alterations Drive Histiocytic NeoplasmsCancer Discovery, 2016
- Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester diseaseBlood, 2014
- Clonal architecture of chronic myelomonocytic leukemiasBlood, 2013